These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9232328)

  • 1. The association of ethnicity and the incidence of mammary carcinoma in situ in women: 11,436 cases from the California Cancer Registry.
    Saltzstein SL
    Cancer Detect Prev; 1997; 21(4):361-9. PubMed ID: 9232328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States.
    Wu X; Matanoski G; Chen VW; Saraiya M; Coughlin SS; King JB; Tao XG
    Cancer; 2008 Nov; 113(10 Suppl):2873-82. PubMed ID: 18980291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urban-rural differences in the management of screen-detected invasive breast cancer and ductal carcinoma in situ in victoria.
    Kok DL; Chang JH; Erbas B; Fletcher A; Kavanagh AM; Henderson MA; Gertig DM
    ANZ J Surg; 2006 Nov; 76(11):996-1001. PubMed ID: 17054549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional variations in breast cancer incidence among California women, 1988-1997.
    Reynolds P; Hurley SE; Quach AT; Rosen H; Von Behren J; Hertz A; Smith D
    Cancer Causes Control; 2005 Mar; 16(2):139-50. PubMed ID: 15868455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling the impact of detecting and treating ductal carcinoma in situ in a breast screening programme.
    McCann J; Treasure P; Duffy S
    J Med Screen; 2004; 11(3):117-25. PubMed ID: 15333269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Declining trends of epithelial ovarian cancer in California.
    Morris CR; Rodriguez AO; Epstein J; Cress RD
    Gynecol Oncol; 2008 Jan; 108(1):207-13. PubMed ID: 18028989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An epidemiologic study of differences between mammary ductal and lobular carcinoma in situ: analysis of 11,436 cases from the California Cancer Registry.
    Saltzstein SL
    Anat Pathol; 1996; 1():193-203. PubMed ID: 9390929
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of community risk factors and resources on breast carcinoma stage at diagnosis.
    Davidson PL; Bastani R; Nakazono TT; Carreon DC
    Cancer; 2005 Mar; 103(5):922-30. PubMed ID: 15651072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced mammographic screening may explain declines in breast carcinoma in older women.
    Kaplan RM; Saltzstein SL
    J Am Geriatr Soc; 2005 May; 53(5):862-6. PubMed ID: 15877565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative epidemiology of breast cancer among men and women in the US, 1996 to 2000.
    Goodman MT; Tung KH; Wilkens LR
    Cancer Causes Control; 2006 Mar; 17(2):127-36. PubMed ID: 16425090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cigarette smoking and risk of breast carcinoma in situ.
    Trentham-Dietz A; Nichols HB; Egan KM; Titus-Ernstoff L; Hampton JM; Newcomb PA
    Epidemiology; 2007 Sep; 18(5):629-38. PubMed ID: 17700252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race/ethnicity and changing US socioeconomic gradients in breast cancer incidence: California and Massachusetts, 1978-2002 (United States).
    Krieger N; Chen JT; Waterman PD; Rehkopf DH; Yin R; Coull BA
    Cancer Causes Control; 2006 Mar; 17(2):217-26. PubMed ID: 16425100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
    Harper S; Lynch J; Meersman SC; Breen N; Davis WW; Reichman MC
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):121-31. PubMed ID: 19124489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
    Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of second primary malignancies in women with papillary thyroid cancer.
    Canchola AJ; Horn-Ross PL; Purdie DM
    Am J Epidemiol; 2006 Mar; 163(6):521-7. PubMed ID: 16421240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age distribution of breast cancer in Lebanon: increased percentages and age adjusted incidence rates of younger-aged groups at presentation.
    El Saghir NS; Shamseddine AI; Geara F; Bikhazi K; Rahal B; Salem ZM; Taher A; Tawil A; El Khatib Z; Abbas J; Hourani M; Seoud M
    J Med Liban; 2002; 50(1-2):3-9. PubMed ID: 12841305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in racial and age disparities in definitive local therapy of early-stage breast cancer.
    Freedman RA; He Y; Winer EP; Keating NL
    J Clin Oncol; 2009 Feb; 27(5):713-9. PubMed ID: 19103731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.